R&D Why are eCOA studies still so challenging? Although eCOA has been in clinical trials for decades, we continue to hit the same road blocks during operational set-up and implementation.
R&D Bridging ethics and efficacy in IRB review of vaccine trials Institutional Review Boards (IRBs) play a key role in evaluating scientific integrity and participant safety.
R&D Don’t sweat an FDA sIRB mandate in clinical research – It’s ... We knew it was coming, and now it’s close.
News Novavax critic Shah Capital ends its activism campaign Shah Capital has ended attempts to exert influence over vaccine firm Novavax, bringing more than years of pressure on management to an end.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
